Alkermes PLC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
ALKS
Alkermes PLCT. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 4,664,563 shares of Alkermes PLC common stock, representing 2.8% of the class.
NASDAQ
ALKS
Alkermes PLCVanguard Portfolio Management has reported beneficial ownership of 5.8% of Alkermes PLC's common stock as of March 31, 2026.
NASDAQ
ALKS
Alkermes PLCVanguard Capital Management has reported beneficial ownership of 8,676,888 shares, representing 5.21% of Alkermes PLC's common stock as of March 31, 2026.
NASDAQ
ALKS
Alkermes PLCThe Vanguard Group has filed an amendment to its Schedule 13G, reporting zero beneficial ownership in Alkermes PLC following an internal realignment.
NASDAQ
ALKS
Alkermes PLCState Street Corporation has reported a 5.2% passive beneficial ownership stake in Alkermes PLC, holding 8,540,351 shares as of September 30, 2025.
NASDAQ
ALKS
Alkermes PLCT. Rowe Price Associates, Inc. has reported a 6.1% beneficial ownership stake in Alkermes PLC, holding over 10 million common shares.
NASDAQ
ALKS
Alkermes PLCState Street Corporation has filed a Schedule 13G, reporting a 4.9% passive beneficial ownership stake in Alkermes PLC.
NASDAQ
ALKS
Alkermes PLCSCHEDULE 13G/A: BlackRock Discloses 15.8% Passive Stake in Alkermes plc
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 15.8% passive beneficial ownership stake in Alkermes plc as of March 31, 2025.
NASDAQ
ALKS
Alkermes PLCWellington Management Group LLP and its affiliates have filed an amended Schedule 13G, reporting a 4.3% beneficial ownership stake in Alkermes Public Limited Company as of December 31, 2024.